Skip to content

Replimune Group REPL Investing Cash Flow

Investing Cash Flow at other companies

Amgen logo
AmgenAMGN
-$716M-60.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$428.9M-166%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
Immunome logo
ImmunomeIMNM
-$12.02M-336%
CG Oncology logo
CG OncologyCGON
-$334.85M-79.3%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$243.83M-812%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's investing cash flow?
Replimune Group (REPL) reported investing cash flow of $75.12M in Q4 2025.
How has Replimune Group's investing cash flow changed year-over-year?
Replimune Group's investing cash flow increased by 262.2% year-over-year, from -$46.32M to $75.12M.
What is the long-term trend for Replimune Group's investing cash flow?
Over 2 years (2023 to 2025), Replimune Group's investing cash flow has grown at a -59.1% compound annual growth rate (CAGR), from -$142.5M to -$23.8M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.